Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Treasury Shares (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Treasury Shares for 16 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 0.68% to $25.0 million in Q4 2025 year-over-year; TTM through Nov 2025 was $25.0 million, a 0.68% increase, with the full-year FY2025 number at $25.0 million, up 0.68% from a year prior.
  • Treasury Shares was $821969.0 for Q4 2025 at Cryo Cell International, down from $6.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $6.8 million in Q3 2025 to a low of $31808.0 in Q1 2024.
  • A 5-year average of $2.9 million and a median of $224999.0 in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: changed 0.0% in 2021, then grew 9.44% in 2022.
  • Cryo Cell International's Treasury Shares stood at $20.8 million in 2021, then increased by 8.74% to $22.6 million in 2022, then rose by 3.53% to $23.4 million in 2023, then grew by 6.08% to $24.9 million in 2024, then increased by 0.68% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Treasury Shares are $25.0 million (Q4 2025), $25.0 million (Q3 2025), and $24.9 million (Q2 2025).